Release Date: 16/06/16 09:19 Summary: Offer under S.708AA(2)-QMN.AX Price Sensitive: Yes Download Document 659.92KB Download
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
Week 32 Wrap: AI is clearly overhyped – but did we see ‘bubble’ burst already? Plus RBA decision; Japan’s wild week & Google ruling